Meet John Schloendorn, an accomplished CEO and scientist with a notable background in biotechnology and biomedical gerontology. He holds a PhD from the Biodesign Institute at Arizona State University and studied at the University of Tübingen. With a wealth of experience in the industry, John has served in various positions, including as CEO at ImmunePath, Inc., Director of the Institute for Biomedical Gerontology at Methuselah Foundation, and is currently the CEO at Gene and Cell Technologies.

John's expertise in biotechnology has allowed him to make significant contributions to the field, particularly in his work on cellular aging and the development of new gene and cell therapies. This has earned him a prominent reputation in the industry, and he is widely recognized for his exceptional leadership skills and ability to steer companies towards success.

As a PhD student, John worked with the Biodesign Institute, one of the most renowned research centers in the field of biotechnology. His studies here led to several groundbreaking discoveries, which have since been the foundation of numerous scientific breakthroughs.

John's experience and contributions to the biotech industry have earned him a reputation as a trailblazer, and his passion for research and development is unmatched. With his extensive background and expertise, John is undoubtedly a key figure in the biotech industry and is poised to make even greater contributions in the future.